Home
Conditions
Myelodysplastic Syndrome

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT01062152

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Loyola University Chicago Cardinal Benardin Cancer Center Maywood, Illinois, United States

Center for Cancer and Blood Disorders Bethesda, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes

NCT00260065

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Boca Raton, Florida, United States

Fort Myers, Florida, United States

View all 21 locations

View Trial Details

Completed

Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)

NCT01481220

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +5 more
Locations: 4 Locations Uppsala, Stockholm, Göteborg, Umeå, Sweden

View Trial Details

Completed

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

NCT00852163

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Baylor University Medical Center Dallas, Texas, United States

View Trial Details

Completed

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

NCT01188798

Conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +26 more
Locations: St . Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome

NCT00806598

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +6 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

NCT00968071

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Observational Study of Iron Overload in Stem Cell Transplantation

NCT00954720

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +19 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Collection and Banking of Leukemia Cells MDS/AML

NCT00809367

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome

NCT00621023

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Myelodysplastic Syndrome

Myelodysplastic Syndrome trial results

Related conditions